Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Watson Fund
AddedFeb 15, 2024
UpdatedJun 28, 2026
Watson Fund

Watson Fund

Operating

Watson Fund, L.P.: A healthcare venture capital fund specializing in early-stage life science investments.

Location
Seattle, WA, US
Founded
2013
Firm
Compare
Portfolio
Employees
Website

Watson Fund, L.P. is a healthcare venture capital firm specializing in early-stage investments across a broad range of life science opportunities. The fund primarily invests in ventures developed and managed by Accelerator Corporation, while reserving capital for follow-on investments in companies meeting predefined milestones. Watson Fund typically participates in Series A and Series B funding rounds.

Notable portfolio companies include ApoGen Biotechnologies, Magnolia Neurosciences, Petra Pharma, and Proniras. The fund's investment strategy focuses on supporting promising healthcare and life science startups through their critical early stages of development. Watson Fund's partnership with Accelerator Corporation provides a unique value proposition for its portfolio companies, potentially offering additional resources and expertise in the life sciences sector.

Watson Fund - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments4
Current Portfolio Count2
Total Portfolio Exits0

Top Investment Stages

Series A3 (75.0%)
Series B1 (25.0%)

Stage Mix

Series A 75%Series B 25%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Proniras logo

Proniras

Magnolia Neurosciences logo

Magnolia Neurosciences

ApoGen Biotechnologies logo

ApoGen Biotechnologies

Petra Pharma logo

Petra Pharma

Watson Fund - Similar Investment Firms

W Fund logo

W Fund

Watson Capital Partners logo

Watson Capital Partners

WRF Capital logo

WRF Capital

wrfseattle.org

Peter Watson Investments logo

Peter Watson Investments

Accelerator Fund logo

Accelerator Fund

Longevity Vision Fund logo

Longevity Vision Fund

longevity.vision

Omega Funds logo

Omega Funds

Accele Venture Partners logo

Accele Venture Partners

Beta Fund logo

Beta Fund

FundRx logo

FundRx

mbxcapital.com

R3 Venture Partners logo

R3 Venture Partners

Angel Physicians Fund logo

Angel Physicians Fund

SeedFolio logo

SeedFolio

Harmonix Fund logo

Harmonix Fund

harmonixfund.com

Walden Catalyst logo

Walden Catalyst

waldencatalyst.com

Watson Fund - Classification

Also Known As
  • Watson Fund, L.P.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 5 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
SIC
  • 6000Depository Institutions
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified